Capecitabine in combination with trastuzumab appears to be of benefit in advanced breast cancer

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1606, 2007-01, pp. : 14-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Patients with advanced gastric cancer may benefit from treatment with a combination of capecitabine and docetaxel

Inpharma, Vol. 1, Iss. 1442, 2004-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Docetaxel/trastuzumab combination therapy for the treatment of breast cancer

By Nabholtz Jean-marc Gligorov Joseph

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 9, 2005-08 ,pp. : 1555-1564

Informa Healthcare

Access to resources Recommend Favorite

Trastuzumab-based combination therapy for breast cancer

By Montemurro Filippo Valabrega Giorgio Aglietta Massimo

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 1, 2004-01 ,pp. : 81-96

Informa Healthcare

Access to resources Recommend Favorite

Trastuzumab/docetaxel/platinum salts for advanced breast cancer

Inpharma, Vol. 1, Iss. 1442, 2004-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

A Novel Combination of Cisplatin, Irinotecan, and Capecitabine in Patients with Advanced Cancer

By Jefford Michael Michael Michael Rosenthal Mark A. Davis Ian D. Green Michael McClure Bev Smith Jennifer Waite Brigid Zalcberg John

Investigational New Drugs, Vol. 22, Iss. 2, 2004-04 ,pp. : 185-192

Springer Publishing Company

Access to resources Recommend Favorite